Cargando…
MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Qualitative differences in the MHC class II antigen processing and presentation pathway may be instrumental in shaping the CD4+ T cell response directed against tumour cells. Efficient loading of many MHC class II alleles with peptides requires the assistance of H2-M, a heterodimeric MHC class II-li...
Autores principales: | Walter, W, Lingnau, K, Schmitt, E, Loos, M, Maeurer, M J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363595/ https://www.ncbi.nlm.nih.gov/pubmed/11027433 http://dx.doi.org/10.1054/bjoc.2000.1415 |
Ejemplares similares
-
Flu DRiPs in MHC Class I Immunosurveillance
por: Wei, Jiajie, et al.
Publicado: (2018) -
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
por: Dhatchinamoorthy, Karthik, et al.
Publicado: (2021) -
Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours
por: Ong, Chrissie E. B., et al.
Publicado: (2022) -
Evasion before invasion: Pre-cancer immunosurveillance
por: Angelova, Mihaela, et al.
Publicado: (2021) -
Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
por: Esteban, F., et al.
Publicado: (1990)